[1]Patent:WO2011/156610,2011,A2.Locationinpatent:Page/Pagecolumn135
[1]CurrentPatentAssignee:CORVUSPHARMACEUTICALSINC-WO2019/46784,2019,A1Locationinpatent:Paragraph0794;0795;0916;0917
[1]BioorganicChemistry,2019,vol.86,p.346-362
1257535-08-2
1423025-98-2
407-22-7
369-03-9
206184-49-8 | Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, hydrate (1:1) | AA002AH9 | MFCD11519982
197516-57-7 | Methyl 2-fluoro-6-methylbenzoate | AA002AS1 | MFCD11226310
19794-97-9 | 1,3-Octadecanediol, 2-amino-, 1-(dihydrogen phosphate), (2S,3R)- | AA002B43 | MFCD00871363
198334-39-3 | 4-(Naphthalen-2-yl)piperidine hydrochloride | AA002BDO | MFCD09839062
198707-57-2 | 2-Propenoic acid, 3-(2,3-dihydro-5-benzofuranyl)- | AA002BMC | MFCD03002828
19920-77-5 | 1-Bromo-3-cyclopentenylbenzene | AA002BWW | MFCD16036124
199657-02-8 | Methyl 2-(methylsulfonyl)benzenecarboxylate | AA002C61 | MFCD03001211
200122-49-2 | Boc-d-arg(mtr)-oh | AA002CH5 | MFCD00151863
200616-40-6 | Fmoc-N-Me-Glu(OtBu)-OH | AA002CSK | MFCD00237028
201008-71-1 | 3,5-dimethyl-1H-pyrazole-4-carbaldehyde | AA002D31 | MFCD03194451